Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy-Reference-Cited by-同舟云学术

Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy

Published:2009-09-15 Issue:2 Volume:37 Page:301-309
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Giovacchini Giampiero,Picchio Maria,Coradeschi Elisa,Bettinardi Valentino,Gianolli Luigi,Scattoni Vincenzo,Cozzarini Cesare,Di Muzio Nadia,Rigatti Patrizio,Fazio Ferruccio,Messa Cristina

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-009-1253-3.pdf

Reference40 articles.

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10–30.

2. Dillioglugil O, Leibman BD, Kattan MW, Seale-Hawkins C, Wheeler TM, Scardino PT. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology 1997;50:93–9.

3. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591–7.

4. de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. [11C]choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003;44:32–8.

5. Picchio M, Messa C, Landoni C, Gianolli L, Sironi S, Brioschi M, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337–40.

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics;European Journal of Nuclear Medicine and Molecular Imaging;2024-03-23

2. Role of <sup>18</sup>F-FCH PET/CT in Detecting Recurrences of Prostate Cancer After Curative Treatments;Molecular Imaging and Radionuclide Therapy;2024-02-23

3. Application of next-generation imaging in biochemically recurrent prostate cancer;Prostate Cancer and Prostatic Diseases;2023-09-07

4. Combination of [68Ga]Ga-PSMA PET/CT and [18F]FDG PET/CT in demonstrating dedifferentiation in castration-resistant prostate cancer;Médecine Nucléaire;2023-08

5. Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer;Current Opinion in Urology;2023-05-11